G1 Therapeutics, Inc. (NASDAQ:GTHX – Get Rating) has been given an average rating of “Moderate Buy” by the six analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target […]
Related Keywords
Hong Kong , Normane Sharpless , , Virtu Financial , Needham Company , Therapeutics Company Profile , Lazard Asset Management , Envestnet Asset Management Inc , Therapeutics Inc , Beacon Pointe Advisors , Hong Kong Ltd , Nasdaq , Ef Hutton Acquisition Co , Research Triangle Park , Get Rating , Asset Management , Kong Ltd , Kwok Kin Wong , G1 Therapeutics , Nasdaq Gthx , Gthx , Medical , Ratings , Consensus ,
vimarsana.com © 2020. All Rights Reserved.